Literature DB >> 16360218

Elevated cytokine levels in children with autism spectrum disorder.

Cynthia A Molloy1, Ardythe L Morrow, Jareen Meinzen-Derr, Kathleen Schleifer, Krista Dienger, Patricia Manning-Courtney, Mekibib Altaye, Marsha Wills-Karp.   

Abstract

UNLABELLED: This study compared production of IL-2, IFN-gamma, IL-4, IL-13, IL-5 and IL-10 in peripheral blood mononuclear cells from 20 children with autism spectrum disorder to those from matched controls. Levels of all Th2 cytokines were significantly higher in cases after incubation in media alone, but the IFN-gamma/IL-13 ratio was not significantly different between cases and controls. Cases had significantly higher IL-13/IL-10 and IFN-gamma/IL-10 than controls.
CONCLUSION: Children with ASD had increased activation of both Th2 and Th1 arms of the adaptive immune response, with a Th2 predominance, and without the compensatory increase in the regulatory cytokine IL-10.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16360218     DOI: 10.1016/j.jneuroim.2005.11.007

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  128 in total

Review 1.  Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?

Authors:  Urs Meyer; Joram Feldon; Olaf Dammann
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

2.  Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2010-11-20       Impact factor: 3.478

3.  Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Authors:  Amanda M Enstrom; Charity E Onore; Judy A Van de Water; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2009-08-08       Impact factor: 7.217

Review 4.  Deficits in bioenergetics and impaired immune response in granulocytes from children with autism.

Authors:  Eleonora Napoli; Sarah Wong; Irva Hertz-Picciotto; Cecilia Giulivi
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

5.  Postnatal exposure to trichloroethylene alters glutathione redox homeostasis, methylation potential, and neurotrophin expression in the mouse hippocampus.

Authors:  Sarah J Blossom; Stepan Melnyk; Craig A Cooney; Kathleen M Gilbert; S Jill James
Journal:  Neurotoxicology       Date:  2012-03-07       Impact factor: 4.294

6.  Newborn screening for autism: in search of candidate biomarkers.

Authors:  Gerald J Mizejewski; Barbara Lindau-Shepard; Kenneth A Pass
Journal:  Biomark Med       Date:  2013-04       Impact factor: 2.851

7.  Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.

Authors:  Dario Siniscalco; Anna Sapone; Catia Giordano; Alessandra Cirillo; Laura de Magistris; Francesco Rossi; Alessio Fasano; James Jeffrey Bradstreet; Sabatino Maione; Nicola Antonucci
Journal:  J Autism Dev Disord       Date:  2013-11

Review 8.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  A Masi; D S Quintana; N Glozier; A R Lloyd; I B Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

9.  Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development.

Authors:  Paula A Garay; Elaine Y Hsiao; Paul H Patterson; A K McAllister
Journal:  Brain Behav Immun       Date:  2012-07-25       Impact factor: 7.217

10.  Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism.

Authors:  Sheikh Fayaz Ahmad; Khairy M A Zoheir; Mushtaq Ahmad Ansari; Ahmed Nadeem; Saleh A Bakheet; Laila Yousef Al-Ayadhi; Mohammad Zeed Alzahrani; Othman A Al-Shabanah; Mohammed M Al-Harbi; Sabry M Attia
Journal:  Mol Neurobiol       Date:  2016-06-25       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.